Literature DB >> 33619537

STING and transplantation: can targeting this pathway improve outcomes?

Cameron S Bader1, Lei Jin2, Robert B Levy1,3.   

Abstract

Stimulator of interferon genes (STING) is an innate immune sensor of cytoplasmic dsDNA originating from microorganisms and host cells. STING plays an important role in the regulation of murine graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and may be similarly activated during other transplantation modalities. In this review, we discuss STING in allo-HSCT and its prospective involvement in autologous HSCT (auto-HSCT) and solid organ transplantation (SOT), highlighting its unique role in nonhematopoietic, hematopoietic, and malignant cell types.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33619537      PMCID: PMC8033456          DOI: 10.1182/blood.2020008911

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  97 in total

1.  STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.

Authors:  Juan Fu; David B Kanne; Meredith Leong; Laura Hix Glickman; Sarah M McWhirter; Edward Lemmens; Ken Mechette; Justin J Leong; Peter Lauer; Weiqun Liu; Kelsey E Sivick; Qi Zeng; Kevin C Soares; Lei Zheng; Daniel A Portnoy; Joshua J Woodward; Drew M Pardoll; Thomas W Dubensky; Young Kim
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

2.  Treatment with an immature dendritic cell-targeting vaccine supplemented with IFN-α and an inhibitor of DNA methylation markedly enhances survival in a murine melanoma model.

Authors:  James T Gordy; Kun Luo; Aakanksha Kapoor; Emily S Kim; Samuel K Ayeh; Petros C Karakousis; Richard B Markham
Journal:  Cancer Immunol Immunother       Date:  2020-01-24       Impact factor: 6.968

3.  STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity.

Authors:  Rana Falahat; Patricio Perez-Villarroel; Adam W Mailloux; Genyuan Zhu; Shari Pilon-Thomas; Glen N Barber; James J Mulé
Journal:  Cancer Immunol Res       Date:  2019-08-28       Impact factor: 11.151

4.  Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA.

Authors:  Leticia Corrales; Seng-Ryong Woo; Jason B Williams; Sarah M McWhirter; Thomas W Dubensky; Thomas F Gajewski
Journal:  J Immunol       Date:  2016-02-29       Impact factor: 5.422

5.  Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling.

Authors:  Meng Michelle Xu; Yang Pu; Dali Han; Yaoyao Shi; Xuezhi Cao; Hua Liang; Xiang Chen; Xiao-Dong Li; Liufu Deng; Zhijian J Chen; Ralph R Weichselbaum; Yang-Xin Fu
Journal:  Immunity       Date:  2017-08-08       Impact factor: 31.745

6.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Authors:  Leticia Corrales; Laura Hix Glickman; Sarah M McWhirter; David B Kanne; Kelsey E Sivick; George E Katibah; Seng-Ryong Woo; Edward Lemmens; Tamara Banda; Justin J Leong; Ken Metchette; Thomas W Dubensky; Thomas F Gajewski
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

Review 7.  Mouse models of bone marrow transplantation.

Authors:  Pavan Reddy; Robert Negrin; Geoffrey R Hill
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

Review 8.  Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.

Authors:  Anita D'Souza; Caitrin Fretham; Stephanie J Lee; Mukta Arora; Janet Brunner; Saurabh Chhabra; Steven Devine; Mary Eapen; Mehdi Hamadani; Parameswaran Hari; Marcelo C Pasquini; Waleska Perez; Rachel A Phelan; Marcie L Riches; J Douglas Rizzo; Wael Saber; Bronwen E Shaw; Stephen R Spellman; Patricia Steinert; Daniel J Weisdorf; Mary M Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-11       Impact factor: 5.609

9.  STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling.

Authors:  Hiroki Ishikawa; Glen N Barber
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

10.  Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells.

Authors:  Julius C Fischer; Michael Bscheider; Sascha Göttert; Erik Thiele Orberg; Stephanie E Combs; Florian Bassermann; Simon Heidegger; Tobias Haas; Hendrik Poeck
Journal:  Sci Rep       Date:  2019-10-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.